Louis Alexopoulos
Corporate Officer/Principal bei Sotos Associates
Profil
Louis Alexopoulos is currently a Partner at Sotos Associates.
Previously, he worked as Secretary & Independent Director at Transition Therapeutics, Inc. from 2011 to 2012.
Aktive Positionen von Louis Alexopoulos
| Unternehmen | Position | Beginn |
|---|---|---|
Sotos Associates
 Sotos Associates Miscellaneous Commercial ServicesCommercial Services Sotos Associates operates as law firm. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Louis Alexopoulos
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Sotos Associates
Sotos Associates Miscellaneous Commercial ServicesCommercial Services Sotos Associates operates as law firm. The company is headquartered in Toronto, Canada. | Commercial Services |
